US46124U1079 - ADR
INVENTIVA SA - ADR
NASDAQ:IVA (4/24/2024, 7:10:37 PM)
3.24
-0.05 (-1.52%)
Inventiva SA is a clinical-stage biopharmaceutical company, which focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis, or NASH, and other diseases with significant unmet medical need. The company is headquartered in Daix, Occitanie and currently employs 117 full-time employees. The company went IPO on 2017-02-15. The firm focuses on the development of therapies in the area of oncology, fibrosis and rare diseases. The Company’s pipeline comprises a number of development programs, such as Clinical Pipeline, Preclinical Pipeline, AbbVie Collaboration and Boehringer-Ingelheim collaboration. Its drug candidates target at the treatment of non-alcoholic steatohepatitis (NASH), systemic sclerosis (SSc), various types of mucopolysaccharidosis (MPS), multiple myeloma, auto-immune disorders, as well as lung cancer, among others. In addition, the Company offers drug discovery services, ranging from target identification to preclinical nomination, in numerous areas, such as silico modelling, biology, screening, absorption, distribution, metabolism and excretion (ADME), pharmacology and histology.
INVENTIVA SA - ADR
50 rue de Dijon, Daix
Daix OCCITANIE 21121
P: 33380447500
CEO: Frederic Cren
Employees: 117
Website: https://inventivapharma.com/
Madrigal's Rezdiffra will have the NASH market all to itself -- at least for a while.
Inventiva (IVA) stock plummeted as it announced a delay in its Phase 3 trial for NASH candidate lanifibranor due to an adverse event. Read more here.
Biopharmaceutical firm Inventiva (IVA) Thursday announced a €35.7 million raise consisting of a capital increase and issuance of royalty certificates.The capital increase would be...
Inventiva (IVA) added ~25% Wednesday on positive data from a Phase 2 trial for its lead candidate lanifibranor targeted at nonalcoholic steatohepatitis. Read more here.
Here you can normally see the latest stock twits on IVA, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: